Leading the Way in Life Science Technologies

Attention Administrator - database is in test mode!

GEN Exclusives

More »

GEN News Highlights

Back to Item »

J&J Completes $30B Deal for Actelion, Which Spins Out Discovery, Early Pipeline

Actelion is now one of Johnson & Johnson’s Janssen Pharmaceutical Companies after J&J today completed its $30 billion cash ...

Forward this item to a colleague:


(Separate multiple addresses by commas)